KURE KraneShares MSCI All China Health Care Index ETF

Overview

Investment Strategy:

KURE seeks to measure the performance of MSCI China All Shares Healthcare 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong, and the United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard (GICS) as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap, and large-cap companies.

China Health Care Sector Highlights:

• China is the second largest healthcare market globally with total healthcare expenditures reaching $479 billion in 2023, after increasing by three times over the past ten years.¹
• There is still opportunity for considerable growth in China’s healthcare market with per capita healthcare spending at just over $340,¹ compared to an average of $4,986 among the Organization for Economic Cooperation and Development (OECD) countries.²
• China’s aging population, rising incomes and increasing urbanization may provide a sustained catalyst for growth in China’s healthcare sector.

KURE features:

• Exposure to Chinese companies listed in the Mainland, Hong Kong and United States that are involved in the healthcare industry, specifically: Biotechnology, General Pharmaceuticals, Care Providers, Medical Devices, and Traditional Chinese Medicine.
• Exposure to companies that benefit from China’s growing middle class and aging population.
• Access to major global healthcare companies that are often not captured by broad indexes.

1.) Data from CEIC as of 12/31/2023. Retrieved on 6/30/2024.
2.) Data from OECD as of 12/31/2024. Retrieved on 6/30/2024.